Cabaletta Bio, Inc. (CABA) has a market capitalization of $313.82M and trades at $3.26. The 52-week range is 0.986-3.78.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2, Earnings Per Share (EPS) of $-1.64.
The stock has a beta of 3.29, operates in the Healthcare sector.